Moneycontrol PRO
Loans
Loans
HomeNewscoronavirusPharma wrap: WHO adds airborne transmission to modes of coronavirus spread; but is it coming too late?

Pharma wrap: WHO adds airborne transmission to modes of coronavirus spread; but is it coming too late?

Airborne transmission allows a virus to enter the upper and lower respiratory tracts.

July 11, 2020 / 20:13 IST

This past week, the World Health Organization (WHO) has updated guidelines on modes of transmission of the virus causing COVID-19 by including the possibility in certain circumstances of airborne transmission. This means the coronavirus could be spread through tiny droplets called aerosols that linger in the air for long periods of time.

The update came on July 9, after an open letter signed by more than 200 scientists pressed the agency to acknowledge the potential role that aerosols play in airborne transmission among people in crowded, indoor settings for prolonged periods of time.

The latest update is important because, after months of debate, the WHO has finally reconsidered its stance on airborne transmission. This will help countries frame appropriate infection control policies, as they try to ease lockdowns.

Airborne transmission allows a virus to enter the upper and lower respiratory tracts. Tuberculosis, chickenpox and measles are other diseases that are known to spread through airborne transmission.

"Outside of medical facilities, some outbreak reports related to indoor crowded spaces have suggested the possibility of aerosol transmission, combined with droplet transmission, for example, during choir practice, in restaurants or in fitness classes," the WHO said in its latest guidance.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"In these events, short-range aerosol transmission, particularly in specific indoor locations, such as crowded and inadequately ventilated spaces over a prolonged period of time with infected persons cannot be ruled out. However, the detailed investigations of these clusters suggest that droplet and fomite transmission could also explain human-to-human transmission within these clusters. Further, the close contact environments of these clusters may have facilitated transmission from a small number of cases to many other people (e.g., super-spreading event), especially if hand hygiene was not performed and masks were not used when physical distancing was not maintained." the statement added.

The WHO said, together with the scientific community, it has been actively discussing and evaluating whether SARS-CoV-2 spreads through the air in the absence of aerosol-generating procedures.

Tighten infection control protocols

To be sure, there are still differences among experts on the airborne transmission of SARS-CoV-2 virus, and definitely, there is a need for more studies and data. However, the latest guidance reinforces the need for the people to compulsorily wear masks, maintain personal hygiene and follow social distancing.

As airborne transmission is added to modes of virus spread, it is important for governments to take this into account while implementing infection control measures and prevention campaigns. India and many other countries have started to ease lockdowns.

Globally, there have been 1.25 million confirmed COVID-19 cases and nearly 4.6 lakh deaths since the outbreak began late last year, according to data compiled by Johns Hopkins University. India reported 7.2 lakh cases and 22,123 deaths so far.

Why WHO took so long to acknowledge airborne transmission

Some experts argue that the WHO should have considered adding airborne transmission to its advisory much earlier. They point out parallels between this and the agency dragging feet on advising countries on use of masks, despite evidence that it is one of the most effective tools to cut transmission.

For several weeks following the onset of the COVID-19 pandemic, the organisation advised that masks should be worn by people who are sick or caregivers of patients with COVID-19. The WHO defended the stance saying that there was not enough evidence to say that healthy people should wear masks. But it did

change its stance on June 5, by advising people to wear face masks when social distancing is not possible, if they are above 60 years of age with comorbidities, or if living in places of community transmission.

The global health agency says that it takes its decision based on evolving evidence, but critics say the agency throughout the pandemic has been slow in its response. They point out the agency's delay in issuing advice against travelling to affected areas.

However, analysts note that the WHO as a multilateral organisation lacks enforcement authority over its member countries and relies on information provided by these nations.

Viswanath Pilla
Viswanath Pilla is a business journalist with 14 years of reporting experience. Based in Mumbai, Pilla covers pharma, healthcare and infrastructure sectors for Moneycontrol.
first published: Jul 11, 2020 08:12 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347